Teal Proteomics 2024 launch - Organ Specific Biological Clock (Now Vero Bioscience)

#21

The email you get when you sign up for their wait list:

Thank you for joining the Vero waitlist – we’re glad you’re here.

You’re now part of a growing community supporting our mission to end age-related chronic disease. As one of our earliest supporters, you’ll be among the first to hear about VIP research opportunities and broader early access to the Vero Organ Age Assessment.

Vero is making significant progress in delivering a groundbreaking approach to measuring biological aging at the organ level—from a single blood draw—revealing where the body is aging fastest so you can act early. You are only as healthy as your oldest organ.

We invite you to explore our published research in Nature, see our latest feature in TIME, and follow us on LinkedIn and X for updates.

We’ll be in touch as new opportunities become available.

In health,
The Vero Team

Questions? Contact us at: hello@verobioscience.com

#22

You’re receiving this email because you joined the Vero waitlist – and today, we’re excited to offer you exclusive access to Vero OrganAge™ , our Stanford-developed blood test that uses proteomics and machine learning to measure the biological age of each organ, revealing where the body is aging fastest.

Through our research partnership with Biograph , the world’s most advanced preventive health and diagnostics clinic, you can now access Vero OrganAge™. Your involvement means participating in a study to learn how lifestyle changes influence biological aging on an organ level and advancing more targeted, preventive healthcare. Enroll in the study today.

Your Opportunity:

A limited number of eligible participants will be invited to join Biograph’s Black Tier program​ at their New York City, NY or San Mateo, CA locations and enroll in this six-month study beginning July 2026. As part of the membership, participants receive exclusive access to Vero OrganAge™ alongside Biograph’s 30+ advanced assessments paired with year-round expert guidance to identify risks across cardiac, cancer, brain, and metabolic health, supporting proactive, long-term care.

To learn more or explore participation, contact Biograph Membership Advisor Meghan M. or enroll directly

Thank you for your trust, your time, and your interest in advancing predictive health.

In Health,
Team Vero

#23

Ugh is it only for people who live near both locations

#24

Aug 18, 2026 11:00 AM Eastern Daylight Time

Vero Combines Stanford’s Proteomic Organ and Cell Aging Technologies to Build a New Clinical and Consumer Tool for Predictive Health

https://www.businesswire.com/news/home/20260818973297/en/Vero-Combines-Stanfords-Proteomic-Organ-and-Cell-Aging-Technologies-to-Build-a-New-Clinical-and-Consumer-Tool-for-Predictive-Health